ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

DYN Dyne Therapeutics Inc

33.30
-0.39 (-1.16%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Dyne Therapeutics Inc DYN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.39 -1.16% 33.30 09:00:00
始値 安値 高値 終値 前日終値
33.00 32.64 33.40 33.07 33.69
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1405:40GLOBEDyne Therapeutics Presents New Preclinical Data for its..
2024/6/1208:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1208:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1208:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1205:32EDGAR2Form 144 - Report of proposed sale of securities
2024/6/1205:25EDGAR2Form 144 - Report of proposed sale of securities
2024/6/1205:22EDGAR2Form 144 - Report of proposed sale of securities
2024/5/3020:30GLOBEDyne Therapeutics to Present at Jefferies Global Healthcare..
2024/5/2820:30GLOBEDyne Therapeutics Announces Closing of Public Offering of..
2024/5/2506:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2506:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2506:00EDGAR2Form 8-K - Current report
2024/5/2310:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2305:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/2220:59EDGAR2Form 8-K - Current report
2024/5/2209:39GLOBEDyne Therapeutics Announces Pricing of $325.5 Million Public..
2024/5/2107:00EDGAR2Form 144 - Report of proposed sale of securities
2024/5/2105:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/2105:01GLOBEDyne Therapeutics Announces Proposed Public Offering of..
2024/5/2020:37EDGAR2Form 8-K - Current report
2024/5/2019:30GLOBEDyne Therapeutics Announces New Clinical Data from ACHIEVE..
2024/5/1921:00GLOBEDyne Therapeutics to Host Virtual Investor Event to Review..
2024/5/1810:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1810:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1810:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1705:26EDGAR2Form 144 - Report of proposed sale of securities
2024/5/1705:23EDGAR2Form 144 - Report of proposed sale of securities
2024/5/1705:18EDGAR2Form 144 - Report of proposed sale of securities
2024/5/0305:10GLOBEDyne Therapeutics Reports First Quarter 2024 Financial..
2024/3/2805:05GLOBEDyne Therapeutics Reports Inducement Grant Under Nasdaq..
2024/3/2721:30GLOBEDyne Therapeutics to Present at the Cantor Virtual Muscular..
2024/3/2520:30GLOBEDyne Therapeutics Announces CEO Transition
2024/3/1320:30GLOBEDyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
2024/3/1206:36EDGAR2Form 144 - Report of proposed sale of securities
2024/3/1206:35EDGAR2Form 144 - Report of proposed sale of securities
2024/3/1206:35EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0906:53EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0810:19EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0810:18EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0810:16EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0522:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/3/0521:41EDGAR2Form 8-K - Current report
2024/3/0521:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0521:35EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0521:30GLOBEDyne Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/3/0211:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0211:33EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0207:08EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0109:49EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2407:23EDGAR2Form 144 - Report of proposed sale of securities

最近閲覧した銘柄

Delayed Upgrade Clock